Intelligent Bio Solutions Inc.
INBS
$2.10
-$0.105-4.77%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 23.21% | 55.28% | 147.58% | 247.39% | 589.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.21% | 55.28% | 98.43% | 137.17% | 165.30% |
| Cost of Revenue | -24.60% | 10.30% | 81.27% | 303.93% | 1,628.42% |
| Gross Profit | 204.22% | 175.56% | 336.50% | 138.12% | 110.70% |
| SG&A Expenses | 4.26% | -3.13% | 15.35% | 27.82% | 35.24% |
| Depreciation & Amortization | 3.64% | -6.30% | 24.26% | 36.28% | 192.94% |
| Other Operating Expenses | -0.38% | 17.75% | 42.41% | 49.59% | 50.04% |
| Total Operating Expenses | 14.26% | 15.87% | 38.18% | 48.76% | 69.06% |
| Operating Income | -11.98% | -7.57% | -21.89% | -28.25% | -41.66% |
| Income Before Tax | 20.09% | 12.03% | 4.44% | 0.14% | -164.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.09% | 12.03% | 4.44% | 0.14% | -164.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.38% | 5.25% | 3.65% | 16.78% | 10.58% |
| Net Income | 20.16% | 12.08% | 4.47% | 0.20% | -165.70% |
| EBIT | -11.98% | -7.57% | -21.89% | -28.25% | -41.66% |
| EBITDA | -12.82% | -7.41% | -41.50% | -128.47% | -342.75% |
| EPS Basic | 96.73% | 95.42% | 85.79% | 67.51% | -35.60% |
| Normalized Basic EPS | 94.42% | 92.35% | 77.15% | 50.81% | 20.42% |
| EPS Diluted | 96.73% | 95.42% | 85.79% | 67.51% | -35.60% |
| Normalized Diluted EPS | 94.42% | 92.35% | 77.15% | 50.81% | 20.42% |
| Average Basic Shares Outstanding | 904.06% | 2,014.57% | 1,769.44% | 1,039.61% | 412.53% |
| Average Diluted Shares Outstanding | 904.06% | 2,014.57% | 1,769.44% | 1,039.61% | 412.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
